MX346428B - Metodo para tratar eccema. - Google Patents

Metodo para tratar eccema.

Info

Publication number
MX346428B
MX346428B MX2014000059A MX2014000059A MX346428B MX 346428 B MX346428 B MX 346428B MX 2014000059 A MX2014000059 A MX 2014000059A MX 2014000059 A MX2014000059 A MX 2014000059A MX 346428 B MX346428 B MX 346428B
Authority
MX
Mexico
Prior art keywords
isothiocyanate functional
treating eczema
eczema
functional surfactant
treating
Prior art date
Application number
MX2014000059A
Other languages
English (en)
Other versions
MX2014000059A (es
Inventor
E Silver Michael
Original Assignee
The William M Yarbrough Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The William M Yarbrough Found filed Critical The William M Yarbrough Found
Publication of MX2014000059A publication Critical patent/MX2014000059A/es
Publication of MX346428B publication Critical patent/MX346428B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un método para tratar eccema, que incluye los pasos de aplicar un agente tensioactivo con grupos funcionales isotiocianato a un área afectada por eccema, en donde el agente tensioactivo con grupos funcionales isotiocianato comprende al menos un grupo funcional isotiocianato asociado con un átomo de carbono alifático y/o aromático del agente tensioactivo con grupos funcionales isotiocianato.
MX2014000059A 2011-06-28 2012-06-28 Metodo para tratar eccema. MX346428B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161502113P 2011-06-28 2011-06-28
US13/348,821 US8865765B2 (en) 2011-01-12 2012-01-12 Method for treating eczema
PCT/US2012/044593 WO2013003560A1 (en) 2011-06-28 2012-06-28 Method for treating eczema

Publications (2)

Publication Number Publication Date
MX2014000059A MX2014000059A (es) 2014-10-24
MX346428B true MX346428B (es) 2017-03-21

Family

ID=47424540

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014000059A MX346428B (es) 2011-06-28 2012-06-28 Metodo para tratar eccema.

Country Status (13)

Country Link
US (6) US8865765B2 (es)
EP (1) EP2725907B1 (es)
JP (1) JP5986631B2 (es)
KR (1) KR101827043B1 (es)
CN (1) CN103717075B (es)
AU (1) AU2012275395B2 (es)
BR (1) BR112013033720B1 (es)
CA (1) CA2840612C (es)
DK (1) DK2725907T3 (es)
ES (1) ES2688360T3 (es)
MX (1) MX346428B (es)
WO (1) WO2013003560A1 (es)
ZA (1) ZA201400005B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI433674B (zh) 2006-12-28 2014-04-11 Infinity Discovery Inc 環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類
US11279674B2 (en) 2011-01-03 2022-03-22 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US10308599B2 (en) 2011-01-03 2019-06-04 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US9962361B2 (en) 2011-01-03 2018-05-08 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US11407713B2 (en) 2011-01-03 2022-08-09 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10273205B2 (en) 2011-01-03 2019-04-30 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
US10640464B2 (en) 2011-01-03 2020-05-05 The William M. Yarbrough Foundation Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
US8933119B2 (en) 2011-01-03 2015-01-13 The William M. Yarbrough Foundation Method for treating phytophotodermatitis
US10647668B2 (en) 2011-01-03 2020-05-12 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US8865765B2 (en) 2011-01-12 2014-10-21 The William M. Yarbrough Foundation Method for treating eczema
US9532969B2 (en) 2011-02-08 2017-01-03 The William M. Yarbrough Foundation Method for treating psoriasis
WO2013066428A1 (en) * 2011-06-28 2013-05-10 The William M. Yarbrough Foundation Method for treating psoriasis
US10335387B2 (en) 2012-07-26 2019-07-02 The William M. Yarbrough Foundation Method for treating infectious diseases with isothiocyanate functional compounds
US9949943B2 (en) 2012-07-26 2018-04-24 The William M. Yarbrough Foundation Method for treating neurodegenerative diseases
US10080734B2 (en) 2012-07-26 2018-09-25 The William M. Yarbrough Foundation Method for treating autism and other neurodevelopmental disorders
US10434082B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
US10441561B2 (en) 2012-07-26 2019-10-15 The William M. Yanbrough Foundation Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
US9839621B2 (en) 2012-07-26 2017-12-12 The William M. Yarbrough Foundation Method for treating bladder cancer
US8865772B2 (en) 2012-07-26 2014-10-21 The William M. Yarbrough Foundation Method for treating skin cancer
US10434081B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Inhibitors of macrophage migration inhibitory factor
US20230110036A1 (en) * 2015-01-12 2023-04-13 The William M Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
AU2016271468B2 (en) 2015-06-04 2020-01-02 Sol-Gel Technologies Ltd. Topical formulations for delivery of hedgehog inhibitor compounds and use thereof
US20170231968A1 (en) * 2016-02-11 2017-08-17 PellePharm, Inc. Method for relief of and treatment of pruritus
US11154486B2 (en) 2020-02-14 2021-10-26 William M. Yarbrough Foundation Detergent compositions for washing urushiol and methods of treating urushiol induced contact dermatitis
US11191708B2 (en) 2020-02-17 2021-12-07 William M. Yarbrough Foundation Sodium lauroyl sarcosinate containing detergent compositions

Family Cites Families (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2905701A (en) 1955-07-29 1959-09-22 Hills Bros Coffee 2-benzofurfuryl isothiocyanate
US3108040A (en) 1960-02-04 1963-10-22 Merck & Co Inc Antiulcer concentrate and process for preparing same
US3725030A (en) 1970-11-20 1973-04-03 Chemagro Corp Limiting plant growth with heterocyclic alkylthiocyanate and isothiocyanate
US3740435A (en) 1970-11-20 1973-06-19 Chemagro Corp Certain heterocyclic isothiocyanates used as fungicides
US4083836A (en) 1974-05-17 1978-04-11 Alfa-Laval Ab Production of rapeseed protein concentrate for human consumption
US3969087A (en) * 1974-08-07 1976-07-13 Ajinomoto Co., Ltd. Gels of nonpolar liquids with N-acyl amino acids and derivatives thereof as gelling agents
US4158656A (en) 1978-02-27 1979-06-19 Canadian Patents And Development Limited Oilseed processing
US4191752A (en) 1978-03-09 1980-03-04 Kanebo, Ltd. Isolation of anti-mutagenic factor from cabbage juice
US5126129A (en) 1988-05-23 1992-06-30 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Cancer therapy using interleukin-2 and flavone compounds
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US5114969A (en) 1989-03-22 1992-05-19 American Health Foundation Method of inhibiting lung tumors, arylalkyl isothiocyanates, and method of synthesizing same
US5231209A (en) 1989-03-22 1993-07-27 American Health Foundation Method of inhibiting lung tumors, arylalkyl isothiocyanates, and method of synthesizing same
CA1336146C (en) 1989-09-29 1995-07-04 Chand Arjun Passey Process for preparing low-calorie nuts
US5057501A (en) 1990-03-13 1991-10-15 Dermatologic Research Corporation Methods for treatment of papulosquamous and eczematous diseases
US5248504A (en) 1992-03-02 1993-09-28 Friedman William H Method of treatment for nasal and sinus dysfunction
US5208249A (en) 1992-08-20 1993-05-04 Clintec Nutrition Co. Method for stimulating intracellular synthesis of glutathione using esters of L-2-oxothiazolidine-4-carboxylate
GB9218714D0 (en) 1992-09-04 1992-10-21 Salim Aws S M Synergistic compositions for hair restoration
US5411986A (en) 1993-03-12 1995-05-02 The Johns Hopkins University Chemoprotective isothiocyanates
US5582818A (en) 1994-01-27 1996-12-10 Ajinomoto Co., Inc. Ultraviolet screening powder and cosmetics
US5589504A (en) 1994-07-26 1996-12-31 Cornell Research Foundation, Inc. Treatment of newborn jaundice
FR2725208B1 (fr) 1994-09-30 1996-11-29 Exsymol Sa Procede de preparation de composes de silicium biologiquement actifs sous forme concentree
US5942597A (en) 1995-08-21 1999-08-24 The Procter & Gamble Company Solvent extraction of polyhydroxyalkanoates from biomass
US5725895B1 (en) 1995-09-15 2000-10-10 Hopkins J School Of Medicine Method of preparing food product from cruciferous seeds
US5686108A (en) 1995-09-27 1997-11-11 Amway Corporation Brassica vegetable supplement and process for manufacture
SE506529C2 (sv) 1996-01-23 1997-12-22 Semper Ab Användning av ett laktoperoxidassystem för framställning av ett läkemedel mot Helicobacter pylori
US6242018B1 (en) 1997-04-11 2001-06-05 Johns Hopkins School Of Medicine Cancer Chemoprotective food products
US6008260A (en) 1998-01-09 1999-12-28 Pharmascience Cancer chemopreventative composition and method
US6414037B1 (en) 1998-01-09 2002-07-02 Pharmascience Pharmaceutical formulations of resveratrol and methods of use thereof
CA2327703C (en) 1998-04-09 2015-08-11 Plant Bioscience Limited Method for selective increasing in the anticarcinogenic glucosinolates in brassica sp
US6046231A (en) 1998-05-15 2000-04-04 The Board Of Trustees Of The University Of Illinois Use of 4'-bromoflavone in a cancer chemopreventative composition and method
US6232316B1 (en) 1998-06-16 2001-05-15 Targacept, Inc. Methods for treatment of CNS disorders
IT1302275B1 (it) 1998-09-25 2000-09-05 Giorgio Panin Formulazione di gel idrofobo a base di vitamina e acetato perapplicazione topica.
JP4205226B2 (ja) 1998-12-03 2009-01-07 日本ゼトック株式会社 細胞賦活剤、それを含む皮膚外用剤及び皮膚洗浄剤
US6166003A (en) 1999-02-17 2000-12-26 Lkt Laboratories, Inc. Heterocyclic compounds for cancer chemoprevention
US6971561B2 (en) 1999-03-01 2005-12-06 Pawel Sawlewicz Auxiliary device for putting on therapeutic compression garments, especially tights, knee-length socks and full-length stockings
US6348220B1 (en) 1999-04-09 2002-02-19 Rutgers, The State University Of New Jersey Phenethylisothiocyanate nutraceutical compositions and methods
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
US6524594B1 (en) * 1999-06-23 2003-02-25 Johnson & Johnson Consumer Companies, Inc. Foaming oil gel compositions
JP3567174B2 (ja) 1999-12-13 2004-09-22 独立行政法人産業技術総合研究所 新規白血病細胞増殖阻害剤
US20080254150A1 (en) 2000-01-03 2008-10-16 Rheins Lawrence A Management of dermatitic symptoms of mammalian integument with emollient disinfectant formulations
US6991811B1 (en) 2000-05-19 2006-01-31 Access Business Group International Llc Echinacea induction of phase II enzymes
US20020164381A1 (en) 2000-06-30 2002-11-07 Medicis Pharmaceutical Corporation Mitocidal compositions and methods
US20030185864A1 (en) * 2000-07-19 2003-10-02 Asako Kobayashi Preventives or remedies for atopic dermatitis
KR100880498B1 (ko) 2000-08-21 2009-01-28 제드 더블유. 파헤이 이소티오시아네이트에 의한 헬리코박터의 처리
US6878751B1 (en) 2000-10-19 2005-04-12 Imperial College Of Science Technology And Medicine Administration of resveratrol to treat inflammatory respiratory disorders
US6436450B1 (en) 2000-12-08 2002-08-20 Access Business Group International Llc Brassica vegetable composition and method for manufacture of same
JP2002284702A (ja) 2001-01-19 2002-10-03 Teika Seiyaku Kk 外用抗真菌製剤
US6680062B2 (en) 2001-10-05 2004-01-20 Color Access, Inc. Anti-irritating rosacea treatment
EP1474158B1 (en) 2001-12-18 2009-10-14 Brassica Foundation for Chemoprotection Research, Inc. Prevention and treatment of oxidative stress disorders by compounds which elevate intracellular levels of glutathione or phase ii detoxification enzymes
NZ516876A (en) * 2002-01-28 2004-05-28 New Zealand Botan Oils Ltd A method of producing an oil extract from the seeds of the plants meadowfoam, brassicas and crambe and its use in skin conditions e.g. eczema, psoriasis and burns
US20030198616A1 (en) 2002-04-23 2003-10-23 Combe Incorporated Moisturizing skin gel and method
US6824796B2 (en) 2002-06-21 2004-11-30 Access Business Group International Llc Extraction of non-polar isothiocyanates from plants
KR100615389B1 (ko) * 2002-08-23 2006-08-25 (주)헬릭서 다래 추출물을 함유하는 알러지성 질환 및 비알러지성염증 질환의 예방 및 개선용 건강 기능 식품
DE10240923A1 (de) 2002-09-02 2004-03-04 Merck Patent Gmbh Flavonoid-Derivate zur Ekzem-Behandlung
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20040156873A1 (en) 2003-02-10 2004-08-12 Gupta Shyam K. Topically Bioavailable Acne and Rosacea Treatment Compositions
WO2004094409A1 (en) 2003-03-27 2004-11-04 Lankenau Institute For Medical Research Novel ido inhibitors and methods of use
NL1023179C2 (nl) 2003-04-14 2004-10-18 Bejo Zaden Bv Brassica varianten met hoge gehaltes aan anti-carcinogene glucosinolaten.
JP4018032B2 (ja) 2003-06-17 2007-12-05 高砂香料工業株式会社 毛髪及び身体洗浄剤組成物
US20050042182A1 (en) 2003-08-13 2005-02-24 Moshe Arkin Topical compositions of urea
WO2005016329A1 (en) 2003-08-13 2005-02-24 Agis Industries (1983) Ltd. Topical compositions of urea and ammonium lactate
EP1667640B1 (de) 2003-09-22 2009-08-05 JUVENA (International) AG Haut- und haarpflegezubereitung enthaltend proteinhydrolysate
US20050095215A1 (en) 2003-11-03 2005-05-05 Popp Karl F. Antimicrobial shampoo compositions
NZ547628A (en) 2003-11-06 2010-07-30 Univ New York State Res Found Methods of treating eczema
US20050100621A1 (en) 2003-11-07 2005-05-12 Popp Karl F. Dermatological compositions
US20050118124A1 (en) 2003-12-01 2005-06-02 Reinhart Gale M. Compositions for treating keratinous surfaces
US20050193448A1 (en) 2004-02-09 2005-09-01 Regents Of The University Of Minnesota Methods for increasing one or more glucosinolates in a plant
US20110028548A1 (en) 2004-04-19 2011-02-03 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
PT1765310E (pt) 2004-05-28 2016-03-01 Oryxe Uma mistura para entrega transdérmica de compostos de baixo e alto peso molecular
WO2006065736A2 (en) 2004-12-14 2006-06-22 Johns Hopkins University Method of extraction of isothiocyanates into oil from glucosinolsate-containing plants
JP2006193572A (ja) * 2005-01-12 2006-07-27 Kiyoshi Ito 竹炭洗浄剤及びその製造方法
CA2593537A1 (en) 2005-01-12 2006-07-20 S.U.L.V.E. Ltd. Methods and pharmaceutical compositions useful for treating psoriasis
US20060211754A1 (en) * 2005-03-16 2006-09-21 Yu Ruey J Compositions comprising N-propanoyl derivatives of amino acids, aminocarbohydrates and derivatives thereof
US20090081138A1 (en) 2005-03-18 2009-03-26 Caudill Seed Company, Incorporated Cancer chemoprotective compositions and natural oils and methods for making same
DK1881823T3 (en) 2005-05-17 2015-03-02 Sarcode Bioscience Inc COMPOSITION AND PROCEDURES FOR TREATMENT OF EYE DISORDERS
US7744937B2 (en) 2005-08-09 2010-06-29 Kraft Foods Global Brands Llc Chemoprotectants from crucifer seeds and sprouts
CN101091705B (zh) 2005-11-15 2010-11-17 无锡杰西医药科技有限公司 异硫氰酸酯类化合物在前列腺疾病及皮肤癌中的应用
JP5308160B2 (ja) 2005-11-15 2013-10-09 景▲かい▼ 程 前立腺疾病及び皮膚癌におけるイソチオシアネート系化合物の使用
JP2008115133A (ja) 2006-11-07 2008-05-22 Kinjirushi Kk アトピー性疾患抑制組成物
US9918934B2 (en) 2006-12-12 2018-03-20 Edgar Joel Acosta-Zara Linker-based lecithin microemulsion delivery vehicles
ES2743043T3 (es) 2007-01-23 2020-02-18 Pharmagra Labs Inc Sulforafano estabilizado
JP5138949B2 (ja) 2007-02-07 2013-02-06 日立オートモティブシステムズ株式会社 車載ゲートウェイ装置
JP5078000B2 (ja) 2007-03-28 2012-11-21 東洋ゴム工業株式会社 研磨パッド
US20080306148A1 (en) 2007-04-13 2008-12-11 The Penn State Research Foundation Anti-cancer compositions and methods
US20080311276A1 (en) 2007-06-12 2008-12-18 Kraft Foods Holdings, Inc. Production of Glucosinolates from Agricultural By-Products & Waste
US20080311192A1 (en) 2007-06-12 2008-12-18 Kraft Foods Holdings, Inc. Enteric-Coated Glucosinolates And Beta-Thioglucosidases
US20110003747A1 (en) 2007-07-20 2011-01-06 Coloumbe Pierre A Use of nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
WO2009046448A1 (en) 2007-10-04 2009-04-09 Intellikine, Inc. Chemical entities and therapeutic uses thereof
EP2205237A1 (en) 2007-10-16 2010-07-14 Johns Hopkins University Methods for protecting the skin from radiation insults
NZ613219A (en) 2008-01-04 2014-11-28 Intellikine Llc Heterocyclic containing entities, compositions and methods
GB2455585B (en) * 2008-01-16 2010-07-28 Ali Reza Rezai-Fard Capsicum seeds for the treatment of eczema and dermatitis
SI2080516T1 (sl) 2008-01-18 2011-09-30 Indena Spa Uporaba iztiocianatnih derivatov kot sredstev proti mielomu
US8003633B1 (en) 2008-04-14 2011-08-23 The Penn State Research Foundation Anti-cancer compositions and methods
US8510127B2 (en) 2008-06-04 2013-08-13 Therapease Cuisine, Inc. Method and system for developing and delivering a therapeutic meal plan program
US20090324522A1 (en) 2008-06-18 2009-12-31 Western Holdings, Llc Skin protectant compositions
CN102124009B (zh) 2008-07-08 2014-07-23 因特利凯公司 激酶抑制剂及其使用方法
EP2161015A1 (en) 2008-09-05 2010-03-10 KPSS-Kao Professional Salon Services GmbH Conditioning composition for hair
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
EP2427195B1 (en) 2009-05-07 2019-05-01 Intellikine, LLC Heterocyclic compounds and uses thereof
WO2010140902A1 (en) * 2009-06-02 2010-12-09 Mark Hampton Inhibitors of macrophage migration inhibitory factor
US8492616B2 (en) 2009-08-31 2013-07-23 Seminis Vegetable Seeds, Inc. Broccoli hybrid PS05151639
ES2593256T3 (es) 2010-05-21 2016-12-07 Infinity Pharmaceuticals, Inc. Compuestos químicos, composiciones y métodos para las modulaciones de cinasas
BE1019434A3 (fr) 2010-07-23 2012-07-03 Auriga Internat Stabilisation du sulforaphane.
BE1019431A3 (fr) * 2010-07-23 2012-07-03 Auriga Internat Procede de synthese d'isothiocyanates et leurs derives et utilisations de ceux-ci.
CA2817577A1 (en) 2010-11-10 2012-05-18 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US8933119B2 (en) * 2011-01-03 2015-01-13 The William M. Yarbrough Foundation Method for treating phytophotodermatitis
US8865765B2 (en) * 2011-01-12 2014-10-21 The William M. Yarbrough Foundation Method for treating eczema
US9532969B2 (en) * 2011-02-08 2017-01-03 The William M. Yarbrough Foundation Method for treating psoriasis
US9098611B2 (en) 2012-11-26 2015-08-04 Intouch Technologies, Inc. Enhanced video interaction for a user interface of a telepresence network
US8835721B2 (en) 2011-06-15 2014-09-16 Seminis Vegetable Seeds, Inc. Broccoli hybrid PX 05181808 and parents thereof
US20130116203A1 (en) 2011-11-07 2013-05-09 Scott R. Rajski Isothiocynates and glucosinolate compounds and anti-tumor compositions containing same
WO2013166421A1 (en) 2012-05-04 2013-11-07 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Melanoma chemoprevention
US9017666B2 (en) 2012-06-05 2015-04-28 Jarrow Formulas, Inc. Broccoli based nutritional supplements
US8865772B2 (en) 2012-07-26 2014-10-21 The William M. Yarbrough Foundation Method for treating skin cancer
AU2013224677B2 (en) 2012-09-13 2017-05-11 Plant Bioscience Limited Brassica oleracea plants with improved nutritional value
US9971561B1 (en) 2016-11-15 2018-05-15 Oath Inc. Volume control

Also Published As

Publication number Publication date
US10111851B2 (en) 2018-10-30
KR20140063566A (ko) 2014-05-27
EP2725907A1 (en) 2014-05-07
KR101827043B1 (ko) 2018-02-07
US20120190742A1 (en) 2012-07-26
EP2725907A4 (en) 2014-10-22
BR112013033720A2 (pt) 2016-08-16
US20170290794A1 (en) 2017-10-12
US20160022624A1 (en) 2016-01-28
CA2840612A1 (en) 2013-01-03
AU2012275395A1 (en) 2014-01-23
CA2840612C (en) 2016-09-13
EP2725907B1 (en) 2018-09-12
US20150038579A1 (en) 2015-02-05
JP2014518271A (ja) 2014-07-28
US20160015676A1 (en) 2016-01-21
US8865765B2 (en) 2014-10-21
DK2725907T3 (en) 2018-12-10
US9655874B2 (en) 2017-05-23
US9649290B2 (en) 2017-05-16
JP5986631B2 (ja) 2016-09-06
AU2012275395B2 (en) 2016-08-11
BR112013033720B1 (pt) 2020-09-29
ES2688360T3 (es) 2018-11-02
CN103717075A (zh) 2014-04-09
US20160015677A1 (en) 2016-01-21
CN103717075B (zh) 2015-11-25
MX2014000059A (es) 2014-10-24
US9687463B2 (en) 2017-06-27
ZA201400005B (en) 2014-10-29
WO2013003560A1 (en) 2013-01-03
US9585860B2 (en) 2017-03-07

Similar Documents

Publication Publication Date Title
MX346428B (es) Metodo para tratar eccema.
WO2013003601A9 (en) Method for treating phytophotodermatitis
PL2711350T3 (pl) Sposób wytwarzania 1,3-butadienu
WO2013083999A3 (en) Nano-enhanced elastomers
MX2013001045A (es) Organoide hepatico, sus usos y metodo de cultivo para obtenerlos.
MY167697A (en) Method for producing 4,4-difluoro-3,4- dihydroisoquinoline derivatives
FR2981910B1 (fr) Atterrisseur, aeronef et procede
MX2013014307A (es) Metodo de tratamiento de celulas madre mesenquinales y su uso en el tratamiento de enfermedades asociadas a estres oxidativo.
WO2012149472A9 (en) Methods, compositions, and kits for treating and preventing neurological conditions
MX2020000205A (es) Metodo para utilizar ciclodextrina.
MX364495B (es) Composición para usarse en el tratamiento de enfermedades oculares relacionadas con ácidos nucleicos.
SG11201402607VA (en) Method for purifying 1,3-butadiene
EP2857500A4 (en) METHOD FOR PRODUCING PANCREATIC HORMONE PRODUCTION CELL, PANCREATIC HORMONE PRODUCTION CELL, AND DIFFERENTIATION / INDUCTION PROMOTER
MX356142B (es) Metodo para producir cetonas macrociclicas.
EP3031905A4 (en) Method for producing pancreatic hormone-producing cell
WO2012168837A3 (en) Method of treating articles with carbon dioxide
IN2014DN03464A (es)
EP3074542A4 (en) Case hardening method for high performance long life martensitic stainless steel bearings
MX2016002217A (es) Compuestos con actividad pesticida.
MX2016004393A (es) Derivados de carboxamida como compuestos pesticidas.
MX2014004970A (es) Metodo y dispositivo para insertar un casquillo de cojinete.
MX2013008361A (es) Procedimiento para la preparacion de derivados 1-h-pirrolidin-2,4-diona.
IL239184B (en) A method for treating agricultural soil with gas
EP2825040A4 (en) PROCESS FOR PREPARING BENZAZOQUOOLIUM (BQS) SALTS, USE OF THE COMPOSITION AS CELLULAR MARKERS AND USE OF THE BIOLOGICAL ACTIVITY OF THIS COMPOSITION
BR112014030576A2 (pt) composto, e, método para controlar micro-organismos.

Legal Events

Date Code Title Description
FG Grant or registration